Uncovering Rare and Genetic Disease Pathophysiology to Identify Therapeutic Targets, Clarifying Disease Biomarkers and Regulatory Endpoints and Implementing Patient-Centric Recruitment Strategies to Accelerate Game-Changing Therapies to Rare Kidney Diseases Patients. Time: 8:00 am to 5:30 pm. Prices: USD 2599.00 - USD 5097.00. Speakers: Robbie McCarthy, USA General Manager, Advicenne S.A., B. Andre Weinstock, Research Director, Alport Syndrome Foundation and More